<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:51:52Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8407866" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8407866</identifier>
        <datestamp>2021-09-01</datestamp>
        <setSpec>intjepid</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Int J Epidemiol</journal-id>
              <journal-id journal-id-type="iso-abbrev">Int J Epidemiol</journal-id>
              <journal-id journal-id-type="publisher-id">ije</journal-id>
              <journal-title-group>
                <journal-title>International Journal of Epidemiology</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0300-5771</issn>
              <issn pub-type="epub">1464-3685</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8407866</article-id>
              <article-id pub-id-type="pmcid">PMC8407866</article-id>
              <article-id pub-id-type="pmc-uid">8407866</article-id>
              <article-id pub-id-type="pmid">34244764</article-id>
              <article-id pub-id-type="pmid">34244764</article-id>
              <article-id pub-id-type="doi">10.1093/ije/dyab106</article-id>
              <article-id pub-id-type="publisher-id">dyab106</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Covid-19</subject>
                </subj-group>
                <subj-group subj-group-type="category-taxonomy-collection">
                  <subject>AcademicSubjects/MED00860</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Predicting and forecasting the impact of local outbreaks of COVID-19: use of SEIR-D quantitative epidemiological modelling for healthcare demand and capacity</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7021-1610</contrib-id>
                  <name>
                    <surname>Campillo-Funollet</surname>
                    <given-names>Eduard</given-names>
                  </name>
                  <xref rid="dyab106-cor1" ref-type="corresp"/>
                  <xref rid="dyab106-aff1" ref-type="aff">1</xref>
                  <!--E.Campillo-Funollet@sussex.ac.uk-->
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0513-1494</contrib-id>
                  <name>
                    <surname>Van Yperen</surname>
                    <given-names>James</given-names>
                  </name>
                  <xref rid="dyab106-aff2" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Allman</surname>
                    <given-names>Phil</given-names>
                  </name>
                  <xref rid="dyab106-aff3" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bell</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <xref rid="dyab106-aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Beresford</surname>
                    <given-names>Warren</given-names>
                  </name>
                  <xref rid="dyab106-aff5" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Clay</surname>
                    <given-names>Jacqueline</given-names>
                  </name>
                  <xref rid="dyab106-aff6" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dorey</surname>
                    <given-names>Matthew</given-names>
                  </name>
                  <xref rid="dyab106-aff6" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Evans</surname>
                    <given-names>Graham</given-names>
                  </name>
                  <xref rid="dyab106-aff7" ref-type="aff">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gilchrist</surname>
                    <given-names>Kate</given-names>
                  </name>
                  <xref rid="dyab106-aff4" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8256-3015</contrib-id>
                  <name>
                    <surname>Memon</surname>
                    <given-names>Anjum</given-names>
                  </name>
                  <xref rid="dyab106-aff8" ref-type="aff">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pannu</surname>
                    <given-names>Gurprit</given-names>
                  </name>
                  <xref rid="dyab106-aff9" ref-type="aff">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Walkley</surname>
                    <given-names>Ryan</given-names>
                  </name>
                  <xref rid="dyab106-aff6" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Watson</surname>
                    <given-names>Mark</given-names>
                  </name>
                  <xref rid="dyab106-aff10" ref-type="aff">10</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9511-8903</contrib-id>
                  <name>
                    <surname>Madzvamuse</surname>
                    <given-names>Anotida</given-names>
                  </name>
                  <xref rid="dyab106-aff2" ref-type="aff">2</xref>
                </contrib>
              </contrib-group>
              <aff id="dyab106-aff1"><label>1</label><institution>School of Life Sciences, Centre for Genome Damage and Stability, University of Sussex</institution>, Brighton, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff2"><label>2</label><institution>Department of Mathematics, School of Mathematical and Physical Sciences, University of Sussex</institution>, Brighton, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff3"><label>3</label><institution>NHS Sussex Commissioners</institution>, Worthing, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff4"><label>4</label><institution>Public Health Intelligence and Adult Social Care, Brighton and Hove City Council</institution>, Hove, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff5"><label>5</label><institution>Planning and Intelligence, Brighton and Hove, Sussex Commissioners</institution>, East Sussex, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff6"><label>6</label><institution>Public Health and Social Research Unit, West Sussex County Council</institution>, Chichester, West Sussex, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff7"><label>7</label><institution>Public Health Intelligence, East Sussex County Council, St Anne’s Crescent</institution>, Lewes, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff8"><label>8</label><institution>Department of Primary Care and Public Health, Brighton and Sussex Medical School</institution>, Brighton, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff9"><label>9</label><institution>Sussex Health and Care Partnership, Millview Hospital</institution>, Hove, East Sussex, <country country="GB">UK</country></aff>
              <aff id="dyab106-aff10"><label>10</label><institution>Sussex Health and Care Partnership</institution>, Lewes, <country country="GB">UK</country></aff>
              <author-notes>
                <corresp id="dyab106-cor1">Corresponding author. School of Life Sciences, Centre for Genome Damage and Stability, University of Sussex, Brighton, UK. E-mail:<email>E.Campillo-Funollet@sussex.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <month>8</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2021-07-09">
                <day>09</day>
                <month>7</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>09</day>
                <month>7</month>
                <year>2021</year>
              </pub-date>
              <volume>50</volume>
              <issue>4</issue>
              <fpage>1103</fpage>
              <lpage>1113</lpage>
              <history>
                <date date-type="accepted">
                  <day>03</day>
                  <month>5</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2021. Published by Oxford University Press on behalf of the International Epidemiological Association.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri xlink:href="dyab106.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="s1">
                  <title>Background</title>
                  <p>The world is experiencing local/regional hotspots and spikes in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19 disease. We aimed to formulate an applicable epidemiological model to accurately predict and forecast the impact of local outbreaks of COVID-19 to guide the local healthcare demand and capacity, policy-making and public health decisions.</p>
                </sec>
                <sec id="s2">
                  <title>Methods</title>
                  <p>The model utilized the aggregated daily COVID-19 situation reports (including counts of daily admissions, discharges and bed occupancy) from the local National Health Service (NHS) hospitals and COVID-19-related weekly deaths in hospitals and other settings in Sussex (population 1.7 million), Southeast England. These data sets corresponded to the first wave of COVID-19 infections from 24 March to 15 June 2020. A novel epidemiological predictive and forecasting model was then derived based on the local/regional surveillance data. Through a rigorous inverse parameter inference approach, the model parameters were estimated by fitting the model to the data in an optimal sense and then subsequent validation.</p>
                </sec>
                <sec id="s3">
                  <title>Results</title>
                  <p>The inferred parameters were physically reasonable and matched up to the widely used parameter values derived from the national data sets by Biggerstaff M, Cowling BJ, Cucunubá ZM et al. (Early insights from statistical and mathematical modeling of key epidemiologic parameters of COVID-19, Emerging infectious diseases. 2020;26(11)). We validate the predictive power of our model by using a subset of the available data and comparing the model predictions for the next 10, 20 and 30 days. The model exhibits a high accuracy in the prediction, even when using only as few as 20 data points for the fitting.</p>
                </sec>
                <sec id="s4">
                  <title>Conclusions</title>
                  <p>We have demonstrated that by using local/regional data, our predictive and forecasting model can be utilized to guide the local healthcare demand and capacity, policy-making and public health decisions to mitigate the impact of COVID-19 on the local population. Understanding how future COVID-19 spikes/waves could possibly affect the regional populations empowers us to ensure the timely commissioning and organization of services. The flexibility of timings in the model, in combination with other early-warning systems, produces a time frame for these services to prepare and isolate capacity for likely and potential demand within regional hospitals. The model also allows local authorities to plan potential mortuary capacity and understand the burden on crematoria and burial services. The model algorithms have been integrated into a web-based multi-institutional toolkit, which can be used by NHS hospitals, local authorities and public health departments in other regions of the UK and elsewhere. The parameters, which are locally informed, form the basis of predicting and forecasting exercises accounting for different scenarios and impacts of COVID-19 transmission.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>COVID-19</kwd>
                <kwd>forecasting</kwd>
                <kwd>healthcare demand</kwd>
                <kwd>SEIR-D epidemiological model</kwd>
                <kwd>parameter inference</kwd>
              </kwd-group>
              <funding-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Higher Education Innovation Fund through the University of Sussex</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Global Challenges Research Fund through the Engineering and Physical Sciences Research Council</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>EP/T00410X/1</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>UK-Africa Postgraduate Advanced Study Institute in Mathematical Sciences</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Wellcome Trust</institution>
                      <institution-id institution-id-type="DOI">10.13039/100010269</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>204833/Z/16/Z</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Health Foundation</institution>
                      <institution-id institution-id-type="DOI">10.13039/100016244</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1902431</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>NIHR</institution>
                      <institution-id institution-id-type="DOI">10.13039/100006662</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>NIHR133761</award-id>
                </award-group>
                <award-group award-type="grant">
                  <funding-source>
                    <institution-wrap>
                      <institution>Dr Perry James (Jim) Browne Research Centre on Mathematics and its Applications (University of Sussex)</institution>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <page-count count="11"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <p>
              <boxed-text id="dyab106-BOX1" position="float">
                <sec>
                  <title>Key Messages</title>
                  <list list-type="bullet">
                    <list-item>
                      <p>We calibrate a susceptible–exposed–infectious–recovered-type model using only hospital-capacity and mortality data, offering an alternative to approaches that require extensive data sets.</p>
                    </list-item>
                    <list-item>
                      <p>We reduce the standard formulation to an observational model that involves only the quantities for which data are available, thus avoiding hidden correlations and identifiability issues.</p>
                    </list-item>
                    <list-item>
                      <p>The model is validated against data for the first 6 months of the COVID-19 pandemic, and we quantify the predictive power of the model to forecast hospital occupancy and mortality.</p>
                    </list-item>
                  </list>
                </sec>
              </boxed-text>
            </p>
            <sec>
              <title>Introduction</title>
              <p>Since SARS-CoV-2 was identified in December 2019,<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref> COVID-19 has swiftly and rapidly spread to nearly all countries in the world, becoming an ongoing global world pandemic that has required unprecedented international, national and regional interventions to try and contain its spread.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B2" ref-type="bibr"><sup>2</sup></xref> Unlike the 1918–1919 H1N1 pandemic, which is considered one of the greatest medical disasters of the twentieth century,<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref> the spread of COVID-19 has unfolded live on multimedia platforms with real-time updates and statistics, with remarkable reporting accuracy,<xref rid="dyab106-B3" ref-type="bibr"><sup>3</sup></xref> and yet reliable, accurate and data-validated epidemiological modelling with forecasting and prediction capabilities remains largely out of reach.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B4" ref-type="bibr"><sup>4–8</sup></xref> Given the lack of widely accessible pharmaceutical interventions, such as vaccination and antiviral drugs, epidemiological modelling has been thrust to the forefront of world organizations’ and governments’ responses, rapid decision-making and public health interventions and policy.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="dyab106-B9" ref-type="bibr"><sup>9–11</sup></xref> Until these pharmaceutical interventions become widely available, the only measures for infection prevention and control are self- or group-isolation (quarantine), testing and contact tracing, physical distancing, decontamination, use of personal protective equipment, wearing masks and hygiene measures. A lot of these unprecedented actions/decisions have resulted in complete lockdowns of countries and economies, and yet these decisions are based on qualitative/quantitative predictions/models using national data sets outside the countries imposing the lockdowns on the basis of these models. A fair criticism of the underlying approach has been the lack of rigorous model validation and applicability given the data sets available at the time of the study, the lack of risk assessment associated with the decisions and their impact on the healthcare demand, capacity and delivery, and subsequently the lack of precision forecasting that is driven by data.<xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyab106-B12" ref-type="bibr"><sup>12</sup></xref> Unfortunately, early epidemiological models needed to make assumptions out of necessity about parameters and disease progression. Therefore, given the lack of data at the early stages of the pandemic, the predictions of these models were almost impossible to validate.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="dyab106-B7" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="dyab106-B9" ref-type="bibr"><sup>9</sup></xref> At the forefront of these epidemiological models that have played a pivotal role in guiding national public health policy and healthcare responses that include the current social distancing, contact tracing and quarantine measures is the well-documented Imperial College London model.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref> The societal and economic impacts of the aforementioned decisions have hardly been quantified; only estimates in the range of trillions of dollars of loss to the world economy are reported.<xref rid="dyab106-B13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="dyab106-B14" ref-type="bibr"><sup>14</sup></xref> A few models dealing with decision-making within the COVID-19 crisis have been reported;<xref rid="dyab106-B9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="dyab106-B15" ref-type="bibr"><sup>15</sup></xref><sup>,</sup><xref rid="dyab106-B16" ref-type="bibr"><sup>16</sup></xref> however, these lack the power of model prediction and forecasting based on appropriate variables and data sets.</p>
              <p>In order to understand the temporal dynamics of COVID-19, a lot of modelling work has been undertaken, focusing primarily on national data sets from China, Italy, Spain, the UK and the USA.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="dyab106-B7" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="dyab106-B9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="dyab106-B17" ref-type="bibr"><sup>17–20</sup></xref> Given the inhomogeneous nature of such data sets, accurate predictions and forecasting of the spread of COVID-19 are challenging.<xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyab106-B21" ref-type="bibr"><sup>21</sup></xref> Where such predictions were made, caveats accompanied these predictions simply because of the lack of rigorous mathematical and statistical validation of the models and the lack of robust data on which mathematical assumptions are based.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="dyab106-B6" ref-type="bibr"><sup>6–9</sup></xref><sup>,</sup><xref rid="dyab106-B19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="dyab106-B20" ref-type="bibr"><sup>20</sup></xref> Forecasting requires ample historical information/data sets, which were lacking during the first wave of COVID-19. Current state-of-the-art forecasting models are based, on the one hand, on time-series analysis without an underlying dynamic epidemiological model.<xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyab106-B22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="dyab106-B23" ref-type="bibr"><sup>23</sup></xref> On the other hand, where forecasting is based on epidemiological models,<xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="dyab106-B24" ref-type="bibr"><sup>24</sup></xref> these lack rigorous validation, sensitivity analysis and analysis with respect to the identifiability of parameters, and therefore have limited forecasting power. An interesting approach is proposed in Bertozzi <italic toggle="yes">et al.</italic> (2020)<xref rid="dyab106-B4" ref-type="bibr"><sup>4</sup></xref> in which three models were presented, depending on the forecasting timescales: an exponential growth model, a self-exciting branching process and the classical susceptible–infected–recovered (SIR) compartmental model. The exponential growth model is assumed valid at the early stages of the pandemic, the self-exciting branching process models the individual-count data going into the development of the pandemic and the SIR is a macroscopic mean-field model that describes the pandemic dynamics as it approaches the peak of the infection and disease. Another interesting and alternative approach is to build machine-learning and artificial-intelligence techniques on top of epidemiological models to allow model predictions and forecasting.<xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref> This approach, so far, has been applied to national data sets from the USA but no regional modelling of this type has been undertaken.</p>
              <p>The use of local data sets is critical for managing and mitigating COVID-19 secondary spikes/waves and reinfection within local communities.<xref rid="dyab106-B25" ref-type="bibr"><sup>25</sup></xref> Already there is ample evidence that local forecasting models could help local/regional authorities to plan lockdowns, restrictions and the opening of schools/universities, as well as planning for healthcare demand and capacity. For example, during the summer of 2020, all the 50 states in the USA started to relax lockdown restrictions, although several states soon after either put on hold their efforts to open fully or started to backtrack due to the resurgence of COVID-19 infections and the start of secondary waves.<xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref> At the same time in the UK, cities such as Leicester, Bradford and Oldham were in the midst of experiencing secondary COVID-19 waves and reinfection. Similarly, in Australia, the city of Melbourne in the state of Victoria was in stage 4 lockdown whereas the remainder of the state was in stage 3 lockdown.<xref rid="dyab106-B10" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="dyab106-B11" ref-type="bibr"><sup>11</sup></xref> During the first wave, Australia was hailed as a global success story in suppressing the spread of COVID-19 and, even at the height of the initial outbreak, it only reported a little over 600 infections a day. A similar story emerged in Spain, with regions in Catalonia undergoing secondary lockdowns. The usefulness of national models, in all these countries, is not clear in terms of being able to predict and forecast the emergence of such spikes, waves or new incidences locally until they have already taken place, which is too late. We propose therefore an alternative quantitative predictive approach that gives local (and national) authorities the ability to predict and forecast COVID-19 scenarios based on their current historical data sets to visualize future dynamic temporal trends of the infection/disease progression for healthcare-planning purposes.</p>
              <p>In this study, we want to demonstrate the usefulness and utility of a locally data-driven epidemiological model, based on recent data sets from the three adjoining regions in Sussex, Southeast England (i.e. Brighton and Hove City Council, East and West Sussex County Councils), to make predictions and forecast to guide local/regional decision-making and healthcare delivery. The approach is based on a modified SIR-type model (<xref rid="dyab106-F1" ref-type="fig">Figure 1</xref>) that has been formulated to reflect the dynamics of the combined Sussex populations of approximately 1.7 million and the mathematical interpretation of the data available.</p>
              <fig position="float" id="dyab106-F1">
                <label>Figure 1</label>
                <caption>
                  <p>Schematic representation of the compartmental model. The susceptible population <italic toggle="yes">S(t)</italic> becomes infected through contacts with infectious individuals, <italic toggle="yes">U</italic>(<italic toggle="yes">t</italic>) and <italic toggle="yes">I</italic>(<italic toggle="yes">t</italic>). Infected individuals incubate the disease first and are not infectious in this state, denoted by <italic toggle="yes">E</italic>(<italic toggle="yes">t</italic>), and after an incubation time, they become infectious<xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref>. The compartment <italic toggle="yes">U</italic>(<italic toggle="yes">t</italic>) accounts for individuals who are not hospitalized; we only observe them if they die, but not if they recover. Many models have split the <italic toggle="yes">U</italic>(<italic toggle="yes">t</italic>) compartment into two separate compartments [see e.g. Blyuss <italic toggle="yes">et al.</italic> (2020)], one to describe individuals who are asymptomatic and the other to describe individuals who have symptoms but do not require hospitalization. However, this approach is constrained by the lack of reliable data sets and therefore models of this nature rely purely on the merits of the simulations with no forecasting capabilities. For such models, it is challenging to obtain reliable data on those who are asymptomatic, especially on the scale of multiple regions/counties. Individuals in the <italic toggle="yes">I</italic>(<italic toggle="yes">t</italic>) compartment are eventually hospitalized and move to compartment <italic toggle="yes">H</italic>(<italic toggle="yes">t</italic>). We added the <italic toggle="yes">H</italic>(<italic toggle="yes">t</italic>) hospital compartment into the model as a transition compartment due to the data we have access to. There are two possible outcomes for COVID-19 infections: recovery or death, denoted by <italic toggle="yes">R</italic> or <italic toggle="yes">D</italic>, respectively, each subscripted with the severity of the infection. We note that there is also a difficulty in gaining reliable data that consider those who are not hospitalized and recover. However, we have reliable data sets for those who die outside of hospital and thus, in the spirit of this model, are related to the not-hospitalized pathway. Coloured and dashed arrows or compartments indicate that data are available: admissions to hospital [red dashed arrow from <italic toggle="yes">I</italic>(<italic toggle="yes">t</italic>) to <italic toggle="yes">H</italic>(<italic toggle="yes">t</italic>)], discharges from hospital [red dashed arrow from <italic toggle="yes">H</italic>(<italic toggle="yes">t</italic>) to <italic toggle="yes">R<sub>H</sub></italic>(<italic toggle="yes">t</italic>)], daily counts of cases in hospital [red dashed <italic toggle="yes">H</italic>(<italic toggle="yes">t</italic>) compartment] and independent weekly data on deaths, both in hospital [red dashed arrow from <italic toggle="yes">H</italic>(<italic toggle="yes">t</italic>) to <italic toggle="yes">D<sub>H</sub></italic>(<italic toggle="yes">t</italic>)] and out of the hospital settings [red dashed arrow from <italic toggle="yes">U</italic>(<italic toggle="yes">t</italic>) to <italic toggle="yes">D<sub>U</sub></italic>(<italic toggle="yes">t</italic>)]. A novel feature of our model and inference method is that, even though information about <italic toggle="yes">U</italic>(<italic toggle="yes">t</italic>) is hard to come by, we can still obtain information by using the red dashed arrow between <italic toggle="yes">U</italic>(<italic toggle="yes">t</italic>) and <italic toggle="yes">D<sub>U</sub></italic>(<italic toggle="yes">t</italic>). The same thing can be said for obtaining the information on <italic toggle="yes">I</italic>(<italic toggle="yes">t</italic>), by using the red dashed arrow between <italic toggle="yes">I</italic>(<italic toggle="yes">t</italic>) and <italic toggle="yes">H</italic>(<italic toggle="yes">t</italic>). The parameters in the model regulate the rates from one compartment to the next and are described in <xref rid="dyab106-T1" ref-type="table">Table 1</xref>. All parameters are inferred from the data using a minimization process under constraints on the total population and the effective reproduction number (Colour version online).</p>
                </caption>
                <graphic xlink:href="dyab106f1" position="float"/>
              </fig>
              <p>The aim of our study is to propose a systematic modelling approach that addresses healthcare demand and capacity at a local level, using the Sussex data sets, by conducting healthcare-demand modelling that naturally leads to a standardized framework to quantify demand generated as a result of COVID-19. This framework will facilitate short-term predictions and long-term scenario forecasting, allowing investigations into the impact of COVID-19 on healthcare provision and planning within the local area and mitigating long-term changes in local hospital demand as a result of further COVID-19 secondary waves. We used the local data sets collected throughout the first wave, which included local daily hospital data and weekly-deaths data. Our approach differs substantially from current state-of-the-art modelling-forecasting approaches where unknown parameters driving epidemiological models have been based on various assumptions that vary substantially from one model to the other as well as variations between the domain expertise of the researchers involved in making those assumptions. We do not use parameter estimates from other studies or regions; instead, we infer these through an inverse-modelling approach by requiring the model to fit to local data in an optimal sense using a maximum-likelihood method. From the full susceptible–exposed–infectious–recovered-dead (SEIR-D) model, we derive the ‘observational model’, which is a representation of the full SEIR-D model described only in terms of the model parameters and compartments that are captured by the mathematical interpretation of data; in this case, the observed quantities are: hospital admissions, bed occupancy, discharges and COVID-19-related deaths (see details in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>, available as <xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> at <italic toggle="yes">IJE</italic> online). To the best of our knowledge, there is no work in which the full SEIR-D model is expressed only in terms of the available data in order to fit the parameters. In this way, by fitting the observational model to the data, we obtain optimally defined values of the unknown model parameters (all the parameters shown in <xref rid="dyab106-F1" ref-type="fig">Figure 1</xref>), accurate to some degree of confidence.<xref rid="dyab106-B26" ref-type="bibr"><sup>26</sup></xref><sup>,</sup><xref rid="dyab106-B27" ref-type="bibr"><sup>27</sup></xref></p>
            </sec>
            <sec sec-type="methods">
              <title>Methods</title>
              <sec>
                <title>Data collection</title>
                <p>As part of the national COVID response, all the National Health Service (NHS) hospitals in England treating COVID-19 patients submitted a Daily Situation Report to NHS England. The regional data for Sussex hospitals were then sent to the Sussex Clinical Commissioning Group, who aggregated the data and combined it with the death registrations (with COVID-19 as the underlying cause of death) from the Office for National Statistics (ONS). The subsets of the hospital data sets included daily admissions, discharges and bed occupancy. The death data set consisted of weekly COVID-19-related deaths in hospitals and community settings (e.g. nursing homes). These data sets corresponded to the first wave of infections from 24 March until 15 June 2020. For the regional population count, the ONS Mid-Year Estimates for 2018 were used. By identifying the compartments where data were available, a mathematical model was generated with the objective of forecasting local hospital demand and capacity, and mortuary requirements. To mitigate changes in policy of what constituted a COVID-19 death and the procedure for recording patients with COVID-19, we account for significant levels of error in the observations. This entails that we do not explicitly distinguish between model and observational errors, but rather we compare the observations with the model solution and consider the difference to be the overall error. In particular, we are including in the error the variation due to the stochastic nature of the epidemics, since the model accounts only for the mean quantities. Although death is an absolute count, the policy regarding what constituted a COVID-19-related death changed frequently throughout the lead-up to and during the lockdown period. Similarly, testing was not optimal when the hospital data collection started and so admissions and occupancy counts were retroactively edited to incorporate newly tested patients, so the balance of total patients between days may not match up. We note that, as detailed below, our model was designed specifically to avoid the use of general testing data. In this way, we avoid dealing with the correlation between detected cases and the number of tests. The number of cases in hospitals are recorded in a systematic way in order to properly isolate the patients to avoid outbreaks and are therefore less dependent on the overall number of tests. In a similar manner, it is well documented that age plays an important role in the severity of a COVID-19 infection;<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B7" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="dyab106-B28" ref-type="bibr"><sup>28</sup></xref><sup>,</sup><xref rid="dyab106-B29" ref-type="bibr"><sup>29</sup></xref> however, at the beginning of the epidemic within the UK, the appropriate age-structured data simply did not exist.</p>
              </sec>
              <sec>
                <title>Data-driven SEIR-D modelling</title>
                <p>The temporal dynamics of the compartmentalized epidemiological model are depicted in <xref rid="dyab106-F1" ref-type="fig">Figure 1</xref>, following classical approaches for formulating SIR models.<xref rid="dyab106-B2" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="dyab106-B30" ref-type="bibr"><sup>30</sup></xref> The mathematical interpretation of the schematic diagram in <xref rid="dyab106-F1" ref-type="fig">Figure 1</xref> leads to a temporal epidemiological dynamical system modelled by a system of ordinary differential equations supported by non-negative initial conditions. The full model is summarized in Equations (1)–(9) in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>, available as <xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> at <italic toggle="yes">IJE</italic> online.</p>
                <p>Our model follows the general principles of SIR-modelling approaches with one clear difference in that this model system is data-driven formulated where we have highlighted in dashed colours those compartments or pathways in <xref rid="dyab106-F1" ref-type="fig">Figure 1</xref> for which data are available within our local area. The physical justification of the SEIR-D model above is well grounded in the modelling literature for COVID-19 and the general theory of epidemiology.<xref rid="dyab106-B2" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="dyab106-B30" ref-type="bibr"><sup>30</sup></xref></p>
              </sec>
              <sec>
                <title>Inferring model parameters given hospital data sets</title>
                <p>From the schematic diagram shown in <xref rid="dyab106-F1" ref-type="fig">Figure 1</xref>, we are interested in finding the optimal set of eight model parameters: <italic toggle="yes">β</italic>, <italic toggle="yes">γ<sub>E</sub></italic>, <italic toggle="yes">p</italic>, <italic toggle="yes">γ<sub>U</sub></italic>, <italic toggle="yes">γ<sub>I</sub></italic>, <italic toggle="yes">γ<sub>H</sub></italic>, <italic toggle="yes">m<sub>U</sub></italic> and <italic toggle="yes">µ<sub>H</sub></italic>, such that the SEIR-D model best fits the observed data. We estimate the parameters in the model in two steps. First, we exploit the linear relationship arising from the mathematical model between mortality in hospitals and discharged patients, depicted by the blue double dashed line and the red dashed line between <italic toggle="yes">H(t)</italic> and <italic toggle="yes">R<sub>H</sub>(t)</italic> in <xref rid="dyab106-F1" ref-type="fig">Figure 1</xref>, respectively, to fit the parameter <italic toggle="yes">η</italic><italic toggle="yes">= µ<sub>H</sub> γ<sub>H</sub></italic><sup>–</sup><sup>1</sup>. The second step is to infer the remaining parameters by expressing the model in terms of the model parameters and compartments of the available data; we call this the observational model. Once the observational model is found, we find the maximum-likelihood estimation corresponding to the negative log-likelihood described in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>, available as <xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> at <italic toggle="yes">IJE</italic> online, by means of the minimization algorithm L-BFGS-B.<xref rid="dyab106-B31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="dyab106-B32" ref-type="bibr"><sup>32</sup></xref> In both cases, we explore the relationship between model parameters where we have access to reliable data sets to mitigate parameter-identifiability issues.<xref rid="dyab106-B33" ref-type="bibr"><sup>33–35</sup></xref> Details of the linear relationship of discharges and deaths in hospital and the observational model are given in the <xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>, available as <xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> at <italic toggle="yes">IJE</italic> online. We note that this two-step fitting approach is not valid in general, but the structure of the model and the data allow us to do so for this particular case, since the parameter optimized in the first step is not present in the second step. In fact, one could perform the fitting in only one step to obtain the same result. The advantage of doing the fitting in two steps is that, in the first step, we can use more appropriate techniques for the linear regression.</p>
              </sec>
              <sec>
                <title>Forecasting and validation</title>
                <p>As outlined above, models of this nature often lack parameter validation and thus lack the ability to predict relatively far into the future.<xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyab106-B9" ref-type="bibr"><sup>9</sup></xref> To validate the predictive power of our modified SEIR-D model (<xref rid="dyab106-F1" ref-type="fig">Figure 1</xref>), we used the previously outlined inference algorithm to obtain new estimates for the model parameters using only a limited number of data points and focused on predicting the hospital admissions, discharges and bed occupancy using a minimum of 12 and a maximum of 51 data points. This is due to the larger hospital data set that we possess, since it is recorded daily rather than weekly. We evaluated the predictive power of a parameter set by performing a prediction for the next 10, 20 and 30 days, starting on the day after the last data point used for the parameter estimation. By comparing the prediction with the available data, we computed the percentage of days that are correctly predicted. It was considered that a day is correctly predicted if it lies within a given tolerance of standard deviations from the available data. This approach quantifies the risk associated with the decision of selecting a certain number of days into the future, e.g. 10, 20 and 30 days. It is important to note that this approach relies on the interpretation of the data, that the data are being collected in a consistent manner and that no policy changes happen within the period of the data set, which would incur a change in public behaviour.</p>
              </sec>
            </sec>
            <sec sec-type="results">
              <title>Results</title>
              <sec>
                <title>Parameter values</title>
                <p>Using the compartmental model along with the novel inference algorithms, we derived the parameter values summarized in <xref rid="dyab106-T1" ref-type="table">Table 1</xref>. <xref rid="dyab106-F2" ref-type="fig">Figure 2</xref> shows the daily number of patients admitted to hospital, those in hospital and those who were discharged, respectively. To demonstrate the accuracy of the fitting procedure, we superimpose the observed data sets and their continuum mathematical counterparts as well as their 95% confidence intervals (95% CIs) for these curves. It can be easily verified that the fitting captures the trends of the data and fits the majority of the data within the 95% CIs. Moreover, small perturbations in most parameters result in small changes to the overall fit of the data, whilst others result in quite a large change in the overall fit (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>, available as <xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> at <italic toggle="yes">IJE</italic> online, for details). This reflects how well characterized a parameter is from the data rather than the sensitivity of the model, since the forecasting pattern is not changing significantly. Accounting for the error in the log-likelihood and the prediction technique, as well as the other sensitivity tests, demonstrates the robustness of the model when the actual data are perturbed and fitted. It is noteworthy that our set of optimal inferred parameters gives a value of effective reproduction number <italic toggle="yes">R</italic><sub>t</sub> = 0.69 throughout the lockdown.</p>
                <fig position="float" id="dyab106-F2">
                  <label>Figure 2</label>
                  <caption>
                    <p>Output of the compartmental model and comparison with data. The solid line represents the output of the model with the parameters inferred from the data. The shaded region depicts the 95% confidence interval (95% CI) computed from the data, i.e. attributing all the error to measurement error. The dots correspond to observed data. Since all data are collected by manual counting and recording, there is a significant amount of noise. Furthermore, we cannot verify that the counting protocol has not changed during the period. There are between 1 and 5 outliers in each data set, out of a total of 82 data points, but generally the model captures the dynamics of the data and the situation (Colour version online).</p>
                  </caption>
                  <graphic xlink:href="dyab106f2" position="float"/>
                </fig>
                <table-wrap position="float" id="dyab106-T1">
                  <label>Table 1</label>
                  <caption>
                    <p>Description of the parameters of the compartmental model and their values when the model is fitted to the data</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="left" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1">Parameter</th>
                        <th rowspan="1" colspan="1">Value</th>
                        <th rowspan="1" colspan="1">Epidemiological meaning</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">β</td>
                        <td rowspan="1" colspan="1">0.142 days<sup>–1</sup></td>
                        <td rowspan="1" colspan="1">Average transmission rate</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">γ<sub>E</sub></italic>
                          <sup>–1</sup>
                        </td>
                        <td rowspan="1" colspan="1">4.67 days</td>
                        <td rowspan="1" colspan="1">Average incubation period</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">p</italic>
                        </td>
                        <td rowspan="1" colspan="1">0.927</td>
                        <td rowspan="1" colspan="1">Fraction of non-hospitalized infections</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">γ<sub>U</sub></italic>
                          <sup>–1</sup>
                        </td>
                        <td rowspan="1" colspan="1">5.02 days</td>
                        <td rowspan="1" colspan="1">Average infectious period (non-hospitalized)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">γ<sub>I</sub></italic>
                          <sup>–1</sup>
                        </td>
                        <td rowspan="1" colspan="1">6.30 days</td>
                        <td rowspan="1" colspan="1">Average infectious period (hospitalized)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">γ<sub>H</sub></italic>
                          <sup>–1</sup>
                        </td>
                        <td rowspan="1" colspan="1">18.3 days</td>
                        <td rowspan="1" colspan="1">Average hospitalization period (recovered)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">m<sub>U</sub></italic>
                        </td>
                        <td rowspan="1" colspan="1">0.0258</td>
                        <td rowspan="1" colspan="1">Infected fatality ratio (non-hospitalized)</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">
                          <italic toggle="yes">µ<sub>H</sub></italic>
                          <sup>–1</sup>
                        </td>
                        <td rowspan="1" colspan="1">16.2 days</td>
                        <td rowspan="1" colspan="1">Average hospitalization period (deaths)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tblfn1">
                      <p>The values are inferred using only the data from the Sussex region, without taking any information from other regions or countries.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Comparisons between our parameters and those used widely in the literature are shown in <xref rid="dyab106-T2" ref-type="table">Table 2</xref>.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="dyab106-B20" ref-type="bibr"><sup>20</sup></xref> It must be noted that the physical interpretations of some of the parameters differ from one model to another, although the overall picture appears plausible. Previous estimates of the average transmission rate and infected fatality ratio were not calibrated locally or were based on data from other regions, e.g. the Imperial College London model and other similar reports. It must be observed that the fraction of non-hospitalized cases is slightly due to its interpretation.</p>
                <table-wrap position="float" id="dyab106-T2">
                  <label>Table 2</label>
                  <caption>
                    <p>Comparison of parameter values from different studies</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="left" span="1"/>
                      <col valign="top" align="left" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th rowspan="1" colspan="1">Parameter</th>
                        <th rowspan="1" colspan="1">This study</th>
                        <th rowspan="1" colspan="1">Ferguson <italic toggle="yes">et al.</italic> (2020)<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref></th>
                        <th rowspan="1" colspan="1">Kissler <italic toggle="yes">et al.</italic> (2020)<xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref></th>
                        <th rowspan="1" colspan="1">Lourenço <italic toggle="yes">et al.</italic> (2020)<xref rid="dyab106-B15" ref-type="bibr"><sup>15</sup></xref></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="1" colspan="1">Average incubation period</td>
                        <td rowspan="1" colspan="1">4.67 days</td>
                        <td rowspan="1" colspan="1">5.1 days</td>
                        <td rowspan="1" colspan="1">4.6 days</td>
                        <td rowspan="1" colspan="1">N/A</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Fraction non-hospitalized cases</td>
                        <td rowspan="1" colspan="1">0.927</td>
                        <td rowspan="1" colspan="1">0.956</td>
                        <td rowspan="1" colspan="1">0.956</td>
                        <td rowspan="1" colspan="1">N/A</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Average infectious period</td>
                        <td rowspan="1" colspan="1">6.30 days</td>
                        <td rowspan="1" colspan="1">5 days</td>
                        <td rowspan="1" colspan="1">5 days</td>
                        <td rowspan="1" colspan="1">4.5 days</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Average hospitalization</td>
                        <td rowspan="1" colspan="1">18.3 days</td>
                        <td rowspan="1" colspan="1">8–16 days</td>
                        <td rowspan="1" colspan="1">6–8 days</td>
                        <td rowspan="1" colspan="1">N/A</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Infected fatality ratio</td>
                        <td rowspan="1" colspan="1">0.0258</td>
                        <td rowspan="1" colspan="1">0.009<xref rid="tblfn3" ref-type="table-fn"><sup>a</sup></xref></td>
                        <td rowspan="1" colspan="1">N/A</td>
                        <td rowspan="1" colspan="1">0.14<xref rid="tblfn4" ref-type="table-fn"><sup>b</sup></xref></td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tblfn2">
                      <p>All the parameters in this study are calibrated from the data; we have not used any parameter estimation from other studies. There is evidence to support that one becomes infectious before presenting symptoms<xref rid="dyab106-B36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="dyab106-B37" ref-type="bibr"><sup>37</sup></xref> and that one becomes infectious after presenting symptoms.<xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref> Different studies use different definitions for the incubation period, e.g. time from exposure to onset of symptoms instead of time from exposure to transmissibility. This therefore has a knock-on effect on the understanding of the average infectious period.</p>
                    </fn>
                    <fn id="tblfn3">
                      <label>a</label>
                      <p>The infected fatality ratio (IFR) in Ferguson <italic toggle="yes">et al.</italic> (2020)<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref> includes all cases whereas, in our model, it is limited to non-hospital infections but is heavily influenced by mortality in care homes.</p>
                    </fn>
                    <fn id="tblfn4">
                      <label>b</label>
                      <p>In Lourenço <italic toggle="yes">et al.</italic> (2020),<xref rid="dyab106-B20" ref-type="bibr"><sup>20</sup></xref> the IFR is limited to severe infections.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec>
                <title>Predictive power of the SEIR-D model</title>
                <p>Using the predictive power method outlined above corresponds to a total of 1776 parameter sets. The resulting values of the parameters from the inference algorithm using the subsets of data are similar to the global fit using all the available data. <xref rid="dyab106-F3" ref-type="fig">Figure 3</xref> shows the results for predictions 10, 20 and 30 days into the future. To our knowledge, this is the first result of its kind to validate the forecasting in this manner.</p>
                <fig position="float" id="dyab106-F3">
                  <label>Figure 3</label>
                  <caption>
                    <p>Validation of the predictive power of the model. We fitted the parameter models using all possible sequences of consecutive admissions, discharge and bed-occupancy data points, from 12 to 51 points. Note that, since there are only 82 data points available, we could not use more than 51 points to validate a prediction for 30 days, otherwise we will not have data to compare with. The predictive power is quantified as the number of days predicted within an accuracy of 1, 2 or 3 standard deviations of the data. There are significant differences in the predictive power for different variables. Admissions and discharges can be predicted accurately using as few as 15 data points to fit the model, whilst hospital-bed occupancy requires approximately 30 data points to reach the same accuracy levels. Admissions/discharges and bed occupancy are different in nature: the former are rates (individuals per day) whereas the latter is an absolute count—this might explain the difference in the predictive power. In addition, bed occupancy is approximately 10 times the value of admissions and discharges (Colour version online).</p>
                  </caption>
                  <graphic xlink:href="dyab106f3" position="float"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion">
              <title>Discussion</title>
              <p>Predicting the local/regional resurgence of COVID-19 is the number-one priority of governments and local authorities in the UK and around the world, to control and halt the local and national transmission of infection. The pandemic itself has thrown to the forefront of science the role and utility of epidemiological modelling at a time when questions of urgency, national importance and uncertainty simultaneously come into play, thereby exposing its current limitations in terms of predictions and forecasting.<xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyab106-B12" ref-type="bibr"><sup>12</sup></xref> A comment by Saltelli <italic toggle="yes">et al.</italic> (2020)<xref rid="dyab106-B12" ref-type="bibr"><sup>12</sup></xref> outlines a manifesto highlighting five ways in which mathematical models should serve society. These include minding the assumptions (the minimal the better), being mindful of model complexities (hubris—balancing the usefulness of the model with the breath of its predictions), being mindful of the interests of the researchers (techniques and methodology can be limited in scope to the expertise of the researchers), being aware of the consequences (mitigate the uncertainty) and finally being mindful of the unknowns (communicating what is unknown is as important as communicating what is known). Our approach is based on these five pillars to ensure that our research outcomes are engrained and driven by reliable local surveillance data with minimal assumptions and an explicit simple data-formulated model. Predictive epidemiological modelling applied to local data has the unique ability to offer local authorities a framework for decision-making that is based on temporal trends of these local data sets. Modelling lessons learnt at the local level can possibly be transferred to the national arena to help guide data acquisition such that data sets are amenable to model-data prediction approaches as well as providing avenues for short-, medium- and long-term forecasting.</p>
              <p>During the early stages of COVID-19, parallels between COVID-19 and the Spanish flu (among other influenza diseases) that killed more than 50 million people with an average age of 28 years were drawn.<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyab106-B4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="dyab106-B22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="dyab106-B38" ref-type="bibr"><sup>38</sup></xref> As a result, to mitigate and prepare for COVID-19 hospitalizations and deaths, national governments and hospitals suspended or postponed important critical diagnostic procedures/treatments, such as cancer diagnosis and treatment. Recent studies have highlighted how predictions need to be transparent and humble in order to instil confidence and invite insight and not blame.<xref rid="dyab106-B12" ref-type="bibr"><sup>12</sup></xref> For a disease such as COVID-19, espoused wrong predictions can have a devastating effect on billions of people around the world in terms of the economy, job security, health, education and societal turmoil, just to mention a few. In this report, we have demonstrated that our inference process and resulting parameters allow us to produce forecasts for up to 30 days into the future to a high accuracy, for quantities of interest such as hospital-bed occupancy, where such a time period can ensure that decisions, and changes in decisions, can be enacted. The underlying temporal dynamics fit the pattern of an infectious disease outbreak and does not rely solely on statistically inferred parameters,<xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref> in the absence of a dynamic model. Such statistical models lack the ability for long-term forecasting. A recent review by Jewell <italic toggle="yes">et al.</italic> (2020)<xref rid="dyab106-B39" ref-type="bibr"><sup>39</sup></xref> established the need for accurate forecasting in the timescales that we have demonstrated to help ease public uncertainty and anxiety by aiding local policy planning in the exact manner that we are using the presented results in our collaborations with the Sussex local authorities and public health departments.</p>
              <p>It is clear from the literature that the accuracy of predictions and forecasting is closely correlated with the underlying theoretical assumptions and the use of pre-determined values of the parameters that are extracted from studies in different contexts, e.g. for populations with different demographics.<xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyab106-B12" ref-type="bibr"><sup>12</sup></xref> This, in turn, is driven by the lack of reliable data sets appropriate for model-data validation and sensitivity analysis. In this study, we have proposed a bottom-up approach in which a model built on local data sets has the ability to guide local decision-making in terms of healthcare demand and capacity, in particular given the surge in COVID-19 secondary spikes/waves.<xref rid="dyab106-B10" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="dyab106-B11" ref-type="bibr"><sup>11</sup></xref> We note that our model is only able to capture secondary waves if their underlying mechanics are the same as for the first outbreak; our model does not incorporate the forecasting of policy changes or other non-epidemiological events. Other widely used publications, such as Ferguson <italic toggle="yes">et al.</italic> (2020),<xref rid="dyab106-B1" ref-type="bibr"><sup>1</sup></xref> used data sets mainly from Wuhan and other national data sets for similar infectious diseases, which means that overall policy and data collection will, in general, differ to the current situation. The important highlight and applicability of our work is that we used local data sets for our modelling, and so we fully understand how the data were collected and know exactly the physical interpretation of the parameters—something that cannot be claimed by using the parameters found in the other publications of predictive modelling.<xref rid="dyab106-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyab106-B39" ref-type="bibr"><sup>39</sup></xref> The SEIR-D model itself is simple and transparent. Moreover, we have designed our approach in such a way that this method can be used by other regions/counties across the UK provided they have the required data and, as such, we have created a toolkit that makes our approach more accessible (<ext-link xlink:href="https://alpha.halogen-health.org" ext-link-type="uri">https://alpha.halogen-health.org</ext-link>). This allows users who are not familiar with mathematical modelling to use our approach and generate their own parameters to inform local policy. We avoid the use of general testing data to overcome the correlations between reported cases and the number of tests performed. Our model does not account for changes in the number of tests performed in hospitals.</p>
              <p>Our modelling framework is not only tailored to deal with COVID-19, but can also be applied to other excess-death situations in summer and winter months that are known to kill thousands of people every year, provided the appropriate data sets exist. Since the framework is built around an SEIR-D model, introducing vaccinations into the model is not mathematically difficult provided we have a good understanding of the vaccination programme with reliable data sets.<xref rid="dyab106-B40" ref-type="bibr"><sup>40–43</sup></xref> Similarly, with the emergence of the new COVID-19 variants (the UK, South Africa, Brazil), e.g. the UK VOC 202012/01 variant that emerged in the Southeast of England in November 2020, we can adapt the work by Kissler <italic toggle="yes">et al.</italic> (2020)<xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref> to provide a multi-strain model whereby an individual catches either one strain or the other.<xref rid="dyab106-B6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="dyab106-B44" ref-type="bibr"><sup>44</sup></xref> Understanding the impact of these will be vitally important in the progression of dealing with the disease, although it is not clear what data will be readily available and our observational model will need to be adapted accordingly.</p>
              <p>Epidemic forecasting and the development of early-warning systems for healthcare demand and capacity have been thrown to the forefront of epidemiological modelling. By working in close collaboration, theoreticians, local-authority public health teams and NHS planners have a unique opportunity to bring novel approaches to healthcare decision-making and planning with forecasting capabilities similar to those used for weather forecasting.</p>
            </sec>
            <sec>
              <title>Subsequent performance of the model post phase one of the lockdown</title>
              <p>We continued to use the model and inference approach in the subsequent months following the lifting of COVID-19 restrictions and lockdowns. <xref rid="dyab106-F4" ref-type="fig">Figure 4</xref> shows the performance of the model for hospital-bed occupancy until the beginning of October 2020. The parameters of the model were refitted twice during the period of March to October to account for policy changes, such as the implementation of lift of lockdowns and other restrictions. In these cases, the decision to refit was based on expert opinion but, in the future, we will use model-selection methods to find the optimal refitting times.</p>
              <fig position="float" id="dyab106-F4">
                <label>Figure 4</label>
                <caption>
                  <p>Hospital-bed occupancy up to 6 October 2020. The model parameters were fitted for three different periods of time (24 March to 22 May, 23 May to 10 August, 11 August to 6 October) to reflect significant policy changes. The performance of the model is stable throughout the depicted period (Colour version online).</p>
                </caption>
                <graphic xlink:href="dyab106f4" position="float"/>
              </fig>
            </sec>
            <sec>
              <title>Ethics approval</title>
              <p>The research design and methodology used only anonymized data sets. This entails that no ethical approval is required.</p>
            </sec>
            <sec>
              <title>Supplementary data</title>
              <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">IJE</italic> online.</p>
            </sec>
            <sec>
              <title>Funding</title>
              <p>This study was supported by the Higher Education Innovation Fund through the University of Sussex (E.C.F., J.V.Y., A.Ma.). This work was partly supported by the Global Challenges Research Fund through the Engineering and Physical Sciences Research Council grant number EP/T00410X/1: UK-Africa Postgraduate Advanced Study Institute in Mathematical Sciences (A.Ma., E.C.F.). E.C.F. is supported by the Wellcome Trust grant number 204833/Z/16/Z. A.Ma’s work was partially funded by grants from the Health Foundation [1902431] and the NIHR [NIHR133761]. This work (A.Ma.) was supported by an individual grant from the Dr Perry James (Jim) Browne Research Centre on Mathematics and its Applications (University of Sussex).</p>
            </sec>
            <sec sec-type="data-availability">
              <title>Data availability</title>
              <p>All data are incorporated into the article and its online <xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>, available as <xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> at <italic toggle="yes">IJE</italic> online.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material id="sup1" position="float" content-type="local-data">
                <label>dyab106_Supplementary_Data</label>
                <media xlink:href="dyab106_supplementary_data.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="ack1">
              <title>Acknowledgements</title>
              <p>J.V.Y. acknowledges postdoctoral support from the Brighton and Hove City Council, East and West Sussex County Councils. A.Ma is a Royal Society Wolfson Research Merit Award Holder funded generously by the Wolfson Foundation. A.Ma is a Distinguished Visiting Scholar to the Universita degli Studi di Bari Aldo Moro, Bari, Italy and the Department of Mathematics, University of Johannesburg, South Africa.</p>
              <sec>
                <title>Author contributions</title>
                <p>The Sussex Modelling Cell (P.A., M.B., W.B., J.C., M.D., G.E., K.G., G.P., R.W., M.W.) conceived of and presented the research questions. E.C.F., J.V.Y. and A.Ma. formulated the epidemiological model, conducted mathematical and statistical analysis and simulations of the model, and drafted the manuscript. P.A. and K.G. generated the data sets from the Sussex Clinical Commissioners and the ONS, and did appropriate checks to assert the completeness and accuracy of the data. E.C.F. and J.V.Y. assembled the figures with substantial contribution from A.Ma. P.A., J.C., M.D., G.E., K.G. and A.Me. A.Me. and G.P. interpreted the data, and critically reviewed and edited the manuscript for intellectual content. All authors contributed to the final manuscript.</p>
              </sec>
              <sec>
                <title>Conflict of interest</title>
                <p>No conflict of interest.</p>
              </sec>
            </ack>
            <ref-list id="ref1">
              <title>References</title>
              <ref id="dyab106-B1">
                <label>1</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Ferguson</surname><given-names>NM</given-names></string-name>, <string-name><surname>Laydon</surname><given-names>D</given-names></string-name>, <string-name><surname>Nedjati-Gilani</surname><given-names>G</given-names></string-name></person-group><etal>et al</etal><source>Impact of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand</source>. 
<publisher-loc>London</publisher-loc>: 
<publisher-name>Imperial College</publisher-name>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="dyab106-B2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blyuss</surname><given-names>KB</given-names></string-name>, <string-name><surname>Kyrychko</surname><given-names>YN.</given-names></string-name></person-group><article-title>Effects of latency and age structure on the dynamics and containment of COVID-19</article-title>. <source>J Theor Biol</source><year>2021</year>;<volume>513</volume>:<fpage>110587</fpage>.<pub-id pub-id-type="pmid">33450286</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dong</surname><given-names>E</given-names></string-name>, <string-name><surname>Du</surname><given-names>H</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>L.</given-names></string-name></person-group><article-title>An interactive web-based dashboard to track COVID-19 in real time</article-title>. <source>Lancet Infect Dis</source><year>2020</year>;<volume>20</volume>:<fpage>533</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">32087114</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bertozzi</surname><given-names>AL</given-names></string-name>, <string-name><surname>Franco</surname><given-names>E</given-names></string-name>, <string-name><surname>Mohler</surname><given-names>G</given-names></string-name>, <string-name><surname>Short</surname><given-names>MB</given-names></string-name>, <string-name><surname>Sledge</surname><given-names>D.</given-names></string-name></person-group><article-title>The challenges of modeling and forecasting the spread of COVID-19</article-title>. <source>Proc Natl Acad Sci USA</source><year>2020</year>;<volume>29</volume>:<fpage>16732</fpage>–<lpage>38</lpage>.</mixed-citation>
              </ref>
              <ref id="dyab106-B5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ferretti</surname><given-names>L</given-names></string-name>, <string-name><surname>Wymant</surname><given-names>C</given-names></string-name>, <string-name><surname>Kendall</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal><article-title>Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing</article-title>. <source>Science</source><year>2020</year>;<volume>368</volume>:<fpage>eabb6936</fpage>.<pub-id pub-id-type="pmid">32234805</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kissler</surname><given-names>SM</given-names></string-name>, <string-name><surname>Tedijanto</surname><given-names>C</given-names></string-name>, <string-name><surname>Goldstein</surname><given-names>E</given-names></string-name>, <string-name><surname>Grad</surname><given-names>YH</given-names></string-name>, <string-name><surname>Lipsitch</surname><given-names>M.</given-names></string-name></person-group><article-title>Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period</article-title>. <source>Science</source><year>2020</year>;<volume>368</volume>:<fpage>860</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">32291278</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Viner</surname><given-names>RM</given-names></string-name>, <string-name><surname>Russell</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Croker</surname><given-names>H</given-names></string-name></person-group><etal>et al</etal><article-title>School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review</article-title>. <source>Lancet Child Adolesc Health</source><year>2020</year>;<volume>4</volume>:<fpage>397</fpage>–<lpage>404</lpage>.<pub-id pub-id-type="pmid">32272089</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Unwin</surname><given-names>HJT</given-names></string-name>, <string-name><surname>Mishra</surname><given-names>S</given-names></string-name>, <string-name><surname>Bradley</surname><given-names>VC</given-names></string-name></person-group><etal>et al</etal><article-title>State-level tracking of COVID-19 in the United States</article-title>. <source>Nat Commun</source><year>2020</year>;<volume>11</volume>:<fpage>1</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">31911652</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B9">
                <label>9</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Alvarez</surname><given-names>FE</given-names></string-name>, <string-name><surname>Argente</surname><given-names>D</given-names></string-name>, <string-name><surname>Lippi</surname><given-names>F.</given-names></string-name></person-group> A simple planning problem for COVID-19 lockdown. <italic toggle="yes">NBER</italic><year>2020</year>; doi:10.3386/w26981.</mixed-citation>
              </ref>
              <ref id="dyab106-B10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blakely</surname><given-names>T</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>J</given-names></string-name>, <string-name><surname>Carvalho</surname><given-names>N</given-names></string-name>, <string-name><surname>Bablani</surname><given-names>L</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>N</given-names></string-name>, <string-name><surname>Stevenson</surname><given-names>M.</given-names></string-name></person-group><article-title>The probability of the 6-week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS-CoV-2</article-title>. <source>Med J Aust</source><year>2020</year>;<volume>213</volume>:<fpage>349</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">32981108</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B11">
                <label>11</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Thompson</surname><given-names>J</given-names></string-name>, <string-name><surname>McClure</surname><given-names>R</given-names></string-name>, <string-name><surname>Blakely</surname><given-names>T</given-names></string-name></person-group>, <etal>et al</etal> Modelling SARS-CoV-2 disease progression in Australia and New Zealand: an agent-based approach to support public health decision-making. <italic toggle="yes">SSRN</italic>, <year>2020</year>; doi:10.2139/ssrn.3712947.</mixed-citation>
              </ref>
              <ref id="dyab106-B12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saltelli</surname><given-names>A</given-names></string-name>, <string-name><surname>Bammer</surname><given-names>G</given-names></string-name>, <string-name><surname>Bruno</surname><given-names>I</given-names></string-name></person-group><etal>et al</etal><article-title>Five ways to ensure that models serve society: a manifesto</article-title>. <source>Nature</source><year>2020</year>;<volume>582</volume>:<fpage>482</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">32581374</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B13">
                <label>13</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Eichenbaum</surname><given-names>M</given-names></string-name>, <string-name><surname>Rebelo</surname><given-names>S</given-names></string-name>, <string-name><surname>Trabandt</surname><given-names>M.</given-names></string-name></person-group> The macroeconomics of epidemics. <italic toggle="yes">NBER</italic>, <year>2020</year>; doi:10.3386/w26882.</mixed-citation>
              </ref>
              <ref id="dyab106-B14">
                <label>14</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Jones</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Philippon</surname><given-names>T</given-names></string-name>, <string-name><surname>Venkateswaran</surname><given-names>V.</given-names></string-name></person-group> Optimal mitigation policies in a pandemic: social distancing and working from home. <italic toggle="yes">NBER</italic>, <year>2020</year>; doi:10.3386/w26984.</mixed-citation>
              </ref>
              <ref id="dyab106-B15">
                <label>15</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Acemoglu</surname><given-names>D</given-names></string-name>, <string-name><surname>Chernozhukov</surname><given-names>V</given-names></string-name>, <string-name><surname>Werning</surname><given-names>I</given-names></string-name>, <string-name><surname>Whinston</surname><given-names>MD</given-names></string-name></person-group>, Optimal targeted lockdowns in a multi-group SIR model. <italic toggle="yes">NBER</italic>, <year>2020</year>; doi:10.3386/w27102.</mixed-citation>
              </ref>
              <ref id="dyab106-B16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hsiang</surname><given-names>S</given-names></string-name>, <string-name><surname>Allen</surname><given-names>D</given-names></string-name>, <string-name><surname>Annan-Phan</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><article-title>The effect of large scale anti-contagion policies on the COVID-19 pandemic</article-title>. <source>Nature</source><year>2020</year>;<volume>584</volume>:<fpage>262</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="pmid">32512578</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B17">
                <label>17</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Docherty</surname><given-names>AB</given-names></string-name>, <string-name><surname>Harrison</surname><given-names>EM</given-names></string-name>, <string-name><surname>Green</surname><given-names>CA</given-names></string-name></person-group>, <etal>et al</etal> Features of 16,749 hospitalised uk patients with covid-19 using the isaric who clinical characterisation protocol. medRxiv, <year>2020</year>; doi:10.1101/2020.04.23.20076042, preprint: not peer-reviewed.</mixed-citation>
              </ref>
              <ref id="dyab106-B18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flaxman</surname><given-names>S</given-names></string-name>, <string-name><surname>Swapnil</surname><given-names>M</given-names></string-name>, <string-name><surname>Gandy</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal>; Imperial College COVID-19 Response Team. 
<article-title>Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe</article-title>. <source>Nature</source><year>2020</year>;<volume>584</volume>:<fpage>257</fpage>–<lpage>61</lpage>.<pub-id pub-id-type="pmid">32512579</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Friston</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Parr</surname><given-names>T</given-names></string-name>, <string-name><surname>Zeidman</surname><given-names>P</given-names></string-name></person-group><etal>et al</etal><article-title>Dynamic casual modelling of COVID-19</article-title>. <source>Wellcome Open Res</source><year>2020</year>;<volume>5</volume>:<fpage>89</fpage>.<pub-id pub-id-type="pmid">32832701</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B20">
                <label>20</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Lourenço</surname><given-names>J</given-names></string-name>, <string-name><surname>Paton</surname><given-names>R</given-names></string-name>, <string-name><surname>Ghafari</surname><given-names>M</given-names></string-name></person-group><etal>et al</etal> Fundamental principles of epidemic spread highlight the immediate need for large-scale serological surveys to assess the stage of the SARS-CoV-2 epidemic. medRxiv, 26 March <year>2020</year>; doi:10.1101/2020.03.24.20042291, preprint-not peer reviewed.</mixed-citation>
              </ref>
              <ref id="dyab106-B21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>JT</given-names></string-name>, <string-name><surname>Leung</surname><given-names>K</given-names></string-name>, <string-name><surname>Leung</surname><given-names>GM.</given-names></string-name></person-group><article-title>Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study</article-title>. <source>Lancet</source><year>2020</year>;<volume>395</volume>:<fpage>689</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">32014114</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petropoulos</surname><given-names>F</given-names></string-name>, <string-name><surname>Makridakis</surname><given-names>S.</given-names></string-name></person-group><article-title>Forecasting the novel coronavirus COVID-19</article-title>. <source>PLoS One</source><year>2020</year>;<volume>15</volume>:<fpage>e0231236</fpage>.<pub-id pub-id-type="pmid">32231392</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>S</given-names></string-name>, <string-name><surname>Diao</surname><given-names>M</given-names></string-name>, <string-name><surname>Yu</surname><given-names>W</given-names></string-name>, <string-name><surname>Pei</surname><given-names>L</given-names></string-name>, <string-name><surname>Lin</surname><given-names>Z</given-names></string-name>, <string-name><surname>Chen</surname><given-names>D.</given-names></string-name></person-group><article-title>Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess Cruise ship: a data-driven analysis</article-title>. <source>Int J Infect Dis</source><year>2020</year>;<volume>93</volume>:<fpage>201</fpage>–<lpage>04</lpage>.<pub-id pub-id-type="pmid">32097725</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Piccolomini</surname><given-names>E</given-names></string-name>, <string-name><surname>Zama</surname><given-names>F.</given-names></string-name></person-group><article-title>Monitoring Italian COVID-19 spread by a forced SEIRD model</article-title>. <source>PLoS One</source><year>2020</year>;<volume>15</volume>:<fpage>e0237417</fpage>.<pub-id pub-id-type="pmid">32760133</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eggo</surname><given-names>RM</given-names></string-name>, <string-name><surname>Dawa</surname><given-names>J</given-names></string-name>, <string-name><surname>Kucharski</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Cucunubá</surname><given-names>ZM.</given-names></string-name></person-group><article-title>The importance of local context in COVID-19 models</article-title>. <source>Nat Comput Sci</source><year>2021</year>;<volume>1</volume>:<fpage>6</fpage>–<lpage>8</lpage>.</mixed-citation>
              </ref>
              <ref id="dyab106-B26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Campillo-Funollet</surname><given-names>E</given-names></string-name>, <string-name><surname>Venkataraman</surname><given-names>C</given-names></string-name>, <string-name><surname>Madzvamuse</surname><given-names>A.</given-names></string-name></person-group><article-title>Bayesian parameter identification for turing systems on stationary and evolving domains</article-title>. <source>Bull Math Biol</source><year>2019</year>;<volume>81</volume>:<fpage>81</fpage>–<lpage>104</lpage>.<pub-id pub-id-type="pmid">30311137</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stuart</surname><given-names>AM.</given-names></string-name></person-group><article-title>Inverse problems: a Bayesian perspective</article-title>. <source>Acta Numer</source><year>2010</year>;<volume>19</volume>:<fpage>451</fpage>–<lpage>59</lpage>.</mixed-citation>
              </ref>
              <ref id="dyab106-B28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Biggerstaff</surname><given-names>M</given-names></string-name>, <string-name><surname>Cowling</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Cucunubá</surname><given-names>ZM</given-names></string-name></person-group><etal>et al</etal>; for the WHO COVID-19 Modelling Parameters Group. 
<article-title>Early insights from statistical and mathematical modelling of key epidemiologic parameters of COVID-19</article-title>. <source>Emerg Infect Dis</source><year>2020</year>;<volume>26</volume>:<fpage>e201074</fpage>.</mixed-citation>
              </ref>
              <ref id="dyab106-B29">
                <label>29</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Brooks-Pollock</surname><given-names>E</given-names></string-name>, <string-name><surname>Christensen</surname><given-names>H</given-names></string-name>, <string-name><surname>Trickey</surname><given-names>A</given-names></string-name></person-group><etal>et al</etal> High COVID-19 transmission potential associated with re-opening universities can be mitigated with layered interventions. medRxiv, <year>2020</year>; doi:10.1101/2020.09.10.20189696, reprint: not peer-reviewed.</mixed-citation>
              </ref>
              <ref id="dyab106-B30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Satsuma</surname><given-names>J</given-names></string-name>, <string-name><surname>Willox</surname><given-names>R</given-names></string-name>, <string-name><surname>Ramani</surname><given-names>A</given-names></string-name>, <string-name><surname>Grammaticos</surname><given-names>B</given-names></string-name>, <string-name><surname>Carstea</surname><given-names>AS.</given-names></string-name></person-group><article-title>Extending the SIR epidemic model</article-title>. <source>Physica A</source><year>2004</year>;<volume>336</volume>:<fpage>369</fpage>–<lpage>75</lpage>.</mixed-citation>
              </ref>
              <ref id="dyab106-B31">
                <label>31</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Fletcher</surname><given-names>R.</given-names></string-name></person-group><source>Practical Methods of Optimization</source>. 
<publisher-loc>Chichester</publisher-loc>: 
<publisher-name>John Wiley &amp; Sons, Inc</publisher-name>, <year>1987</year>.</mixed-citation>
              </ref>
              <ref id="dyab106-B32">
                <label>32</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Malouf</surname><given-names>R.</given-names></string-name></person-group> A comparison of algorithms for maximum entropy parameter estimation. In: <person-group person-group-type="editor"><string-name><surname>Roth</surname><given-names>D</given-names></string-name>, <string-name><surname>van den Bosch</surname><given-names>A</given-names></string-name></person-group> (eds). <italic toggle="yes">Natural Language Learning: Sixth International Conference, CoNLL 2002, Taipei, Taiwan, August, 2002 Proceedings.</italic> USA: Association for Computational Linguistics, <year>2002</year>.</mixed-citation>
              </ref>
              <ref id="dyab106-B33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boileau</surname><given-names>T</given-names></string-name>, <string-name><surname>Leboeuf</surname><given-names>N</given-names></string-name>, <string-name><surname>Nahid-Mobarakeh</surname><given-names>B</given-names></string-name>, <string-name><surname>Meibody-Tabar</surname><given-names>F.</given-names></string-name></person-group><article-title>Online identification of PMSM parameters: parameter identifiability and estimator comparative study</article-title>. <source>IEEE Trans on Ind Applicat</source><year>2011</year>;<volume>47</volume>:<fpage>1944</fpage>–<lpage>57</lpage>.</mixed-citation>
              </ref>
              <ref id="dyab106-B34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Raue</surname><given-names>A</given-names></string-name>, <string-name><surname>Karlsson</surname><given-names>J</given-names></string-name>, <string-name><surname>Saccomani</surname><given-names>MP</given-names></string-name>, <string-name><surname>Jirstrand</surname><given-names>M</given-names></string-name>, <string-name><surname>Timmer</surname><given-names>J.</given-names></string-name></person-group><article-title>Comparison of approaches for parameter identifiability analysis of biological systems</article-title>. <source>Bioinformatics</source><year>2014</year>;<volume>30</volume>:<fpage>1440</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">24463185</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>H</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>H</given-names></string-name>, <string-name><surname>Miao</surname><given-names>H</given-names></string-name>, <string-name><surname>Perelson</surname><given-names>AS.</given-names></string-name></person-group><article-title>Parameter identifiability and estimation of HIV/AIDS dynamic models</article-title>. <source>Bull Math Biol</source><year>2008</year>;<volume>70</volume>:<fpage>785</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">18247096</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ganyani</surname><given-names>T</given-names></string-name>, <string-name><surname>Kremer</surname><given-names>C</given-names></string-name>, <string-name><surname>Chen</surname><given-names>D</given-names></string-name></person-group><etal>et al</etal><article-title>Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020</article-title>. <source>Eurosurveillance</source><year>2020</year>;<volume>25</volume>:<fpage>2000257</fpage>.</mixed-citation>
              </ref>
              <ref id="dyab106-B37">
                <label>37</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Xia</surname><given-names>W</given-names></string-name>, <string-name><surname>Liao</surname><given-names>J</given-names></string-name>, <string-name><surname>Li</surname><given-names>C</given-names></string-name></person-group><etal>et al</etal> Transmission of corona virus disease 2019 during the incubation period may lead to a quarantine loophole. medRxiv, <year>2020</year>; doi:10.1101/2020.03.06.20031955, preprint: not peer-reviewed.</mixed-citation>
              </ref>
              <ref id="dyab106-B38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Verity</surname><given-names>R</given-names></string-name>, <string-name><surname>Okell</surname><given-names>LC</given-names></string-name>, <string-name><surname>Dorigatti</surname><given-names>I</given-names></string-name></person-group><etal>et al</etal><article-title>Estimates of the severity of coronavirus disease 2019: a model-based analysis</article-title>. <source>Lancet Infect Dis</source><year>2020</year>;<volume>20</volume>:<fpage>669</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">32240634</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jewell</surname><given-names>NP</given-names></string-name>, <string-name><surname>Lewnard</surname><given-names>JA</given-names></string-name>, <string-name><surname>Jewell</surname><given-names>BL.</given-names></string-name></person-group><article-title>Predictive mathematical models of the COVID-19 pandemic: underlying principles and value of projections</article-title>. <source>JAMA</source><year>2020</year>;<volume>323</volume>:<fpage>1893</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="pmid">32297897</pub-id></mixed-citation>
              </ref>
              <ref id="dyab106-B40">
                <label>40</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Diekmann</surname><given-names>O</given-names></string-name>, <string-name><surname>Heesterbeek</surname><given-names>JAP.</given-names></string-name></person-group><source>Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation</source>. 
<publisher-loc>Chichester</publisher-loc>: 
<publisher-name>John Wiley &amp; Sons, Inc</publisher-name>., <year>2000</year>.</mixed-citation>
              </ref>
              <ref id="dyab106-B41">
                <label>41</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Gozzi</surname><given-names>N</given-names></string-name>, <string-name><surname>Bajardi</surname><given-names>P</given-names></string-name>, <string-name><surname>Perra</surname><given-names>N.</given-names></string-name></person-group> The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout. medRxivdoi, 9 January <year>2021</year>; doi:10.1101/2021.01.09.21249480, preprint: not peer-reviewed.</mixed-citation>
              </ref>
              <ref id="dyab106-B42">
                <label>42</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Hogan</surname><given-names>A</given-names></string-name>, <string-name><surname>Winskill</surname><given-names>P</given-names></string-name>, <string-name><surname>Watson</surname><given-names>O</given-names></string-name></person-group><etal>et al</etal><source>Modelling the Allocation and Impact of a COVID-19 Vaccine</source>. 
<publisher-loc>London</publisher-loc>: 
<publisher-name>Imperial College</publisher-name>, <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="dyab106-B43">
                <label>43</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>McDonnell</surname><given-names>A</given-names></string-name>, <string-name><surname>Van Exan</surname><given-names>R</given-names></string-name>, <string-name><surname>Lloyd</surname><given-names>S</given-names></string-name></person-group><etal>et al</etal><italic toggle="yes">COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines</italic>. CGD, <year>2020</year>. <ext-link xlink:href="https://covid19.ariadnelabs.org/wp-content/uploads/sites/6/2020/10/COVID-19-Vaccine-Predictions-Full.pdf(January2021,datalastaccessed" ext-link-type="uri">https://covid19.ariadnelabs.org/wp-content/uploads/sites/6/2020/10/COVID-19-Vaccine-Predictions-Full.pdf (January 2021, data last accessed</ext-link>).</mixed-citation>
              </ref>
              <ref id="dyab106-B44">
                <label>44</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Davies</surname><given-names>NG</given-names></string-name>, <string-name><surname>Barnard</surname><given-names>RC</given-names></string-name>, <string-name><surname>Jarvis</surname><given-names>CI</given-names></string-name></person-group>, <etal>et al</etal><italic toggle="yes">Estimated Transmissibility and Severity of Novel SARS-CoV-2 Variant of Concern 202012/01 in England</italic>. medRxiv, 26 December <year>2020</year>; doi:10.1101/2020.12.24.20248822, preprint: not peer-reviewed.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
